Results 61 to 70 of about 27,037 (216)
Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis
The Scientific World Journal, 2012 Background. The rise of highly resistant bacteria creates a persistent urge to develop new antimicrobial agents. This paper investigates the application of the lipopeptide antibiotic daptomycin in infections involving the human bone. Methods. Compressive
Steffen B. Rosslenbroich +6 more
doaj +1 more source
Iatreia, 2017 Introduction: Second-line drugs such as linezolid and daptomycin are used for treatment of vancomycin-resistant Enterococcus (VRE) infections. Objective: A systematic review to evaluate treatment of VRE bacteremia with linezolid versus daptomycin ...
Caicedo-Ochoa, Edgar Yaset +4 more
doaj +1 more source
, 2011 Background: The pharmacokinetics (PK) and safety of daptomycin have not yet been studied in an adult Taiwanese population. Methods: A total of 13 healthy adult Taiwanese subjects (7 males and 6 females) were enrolled to receive a 5-day course of multiple
梁修豪;盛望徽;黃昱璁;林慧玲;張上淳 +1 more
core +1 more source
Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review
Brazilian Journal of Infectious Diseases, 2019 Backgroud: Daptomycin has been used in bone and joint infections (BJI) and prosthesis joint infections (PJI) considering spectrum of activity and biofilm penetration.
João Paulo Telles +2 more
doaj +1 more source
Microbiology Spectrum, 2022 Elasnin is a recently reported antibiofilm agent that is effective against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
Jordy Evan Sulaiman +3 more
doaj +1 more source
Антибиотики и Химиотерапия, 2020 To predict the anti-mutant effects of antibiotic combinations against Staphylococcus aureus, the mutant prevention concentrations (MPCs) of linezolid and daptomycin were determined at a linezolid-to-daptomycin concentration ratio that corresponds to the ...
K. N. Alieva +3 more
doaj +3 more sources
Pharmaceutics, 2022 The aims of this study are (i) to develop a population pharmacokinetic/pharmacodynamic model of daptomycin in patients with normal and impaired renal function, and (ii) to establish the optimal dose recommendation of daptomycin in clinical practice ...
Teresa García-Martínez +5 more
doaj +1 more source
, 2014 Background and Purpose: The safety and efficacy of treating serious infections caused by Staphylococcus aureus with daptomycin in a Taiwanese population were studied.
張上淳 +1 more
core +1 more source
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis [PDF]
, 2006 OBJECTIVES: To test the efficacy of daptomycin, a cyclic lipopeptide antibiotic, against a methicillin-susceptible Staphylococcus aureus strain in experimental rabbit meningitis and to determine its penetration into non-inflamed and inflamed meninges ...
Stucki, Armin +4 more
core +1 more source
, 2023 Daptomycin is a cyclic lipopeptide antibiotic that targets the lipid membrane of Gram-positive bacteria. Membrane fluidity and charge can affect daptomycin activity, but its mechanisms are poorly understood because it is challenging to study daptomycin ...
Michael, Marty +9 more
core +1 more source